ASX - By Stock
|
FGR |
Re:
Graphene: Current research and development
|
|
imagine
|
451 |
190K |
1 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
451
|
190K
|
1
|
|
ASX - By Stock
|
FGR |
Re:
graphene
|
|
imagine
|
170 |
96K |
4 |
24/09/19 |
24/09/19 |
ASX - By Stock
|
170
|
96K
|
4
|
|
ASX - By Stock
|
FGR |
news on graphene
|
|
imagine
|
0 |
5.7K |
1 |
17/08/19 |
17/08/19 |
ASX - By Stock
|
0
|
5.7K
|
1
|
|
ASX - By Stock
|
FGR |
Re:
graphene
|
|
imagine
|
170 |
96K |
4 |
10/07/19 |
10/07/19 |
ASX - By Stock
|
170
|
96K
|
4
|
|
ASX - By Stock
|
FGR |
Re:
graphene
|
|
imagine
|
170 |
96K |
5 |
10/07/19 |
10/07/19 |
ASX - By Stock
|
170
|
96K
|
5
|
|
ASX - By Stock
|
FGR |
graphene
|
|
imagine
|
170 |
96K |
6 |
10/07/19 |
10/07/19 |
ASX - By Stock
|
170
|
96K
|
6
|
|
Political Debate
|
|
Re:
"Albo"
|
|
imagine
|
16 |
2.7K |
13 |
23/05/19 |
23/05/19 |
Political Debate
|
16
|
2.7K
|
13
|
|
Political Debate
|
|
Re:
Bill Shorten - He looks shifty
|
|
imagine
|
98 |
16K |
9 |
17/04/19 |
17/04/19 |
Political Debate
|
98
|
16K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Catalysts for $1B MC?
|
|
imagine
|
173 |
62K |
8 |
22/11/18 |
22/11/18 |
ASX - By Stock
|
173
|
62K
|
8
|
|
ASX - By Stock
|
BIT |
biotech daily
|
|
imagine
|
0 |
510 |
3 |
19/11/18 |
19/11/18 |
ASX - By Stock
|
0
|
510
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data
|
|
imagine
|
1.0K |
393K |
16 |
18/11/18 |
18/11/18 |
ASX - By Stock
|
1.0K
|
393K
|
16
|
|
ASX - By Stock
|
BIT |
Biotron 2010
|
|
imagine
|
4 |
1.7K |
1 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
4
|
1.7K
|
1
|
|
ASX - By Stock
|
CYP |
Japan hurries to regain lead in race for stem cell therapies
|
|
imagine
|
11 |
4.0K |
21 |
02/10/18 |
02/10/18 |
ASX - By Stock
|
11
|
4.0K
|
21
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
imagine
|
154 |
60K |
4 |
19/08/18 |
19/08/18 |
ASX - By Stock
|
154
|
60K
|
4
|
|
ASX - By Stock
|
CYP |
Unique stem cells as a potential asthma treatment
|
|
imagine
|
0 |
698 |
20 |
07/07/18 |
07/07/18 |
ASX - By Stock
|
0
|
698
|
20
|
|
ASX - By Stock
|
CYP |
Re:
Wilson desk note
|
|
imagine
|
2 |
1.5K |
1 |
02/07/18 |
02/07/18 |
ASX - By Stock
|
2
|
1.5K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
MSCs Effective in Preclinical Model of Diabetic Wounds
|
|
imagine
|
1 |
816 |
2 |
25/06/18 |
25/06/18 |
ASX - By Stock
|
1
|
816
|
2
|
|
ASX - By Stock
|
CYP |
MSCs Effective in Preclinical Model of Diabetic Wounds
|
|
imagine
|
1 |
816 |
11 |
25/06/18 |
25/06/18 |
ASX - By Stock
|
1
|
816
|
11
|
|
ASX - By Stock
|
CYP |
Cynata stem cell progress
|
|
imagine
|
11 |
7.9K |
17 |
23/06/18 |
23/06/18 |
ASX - By Stock
|
11
|
7.9K
|
17
|
|
ASX - By Stock
|
CYP |
Re:
Effective in Preclinical Model of Diabetic Wounds
|
|
imagine
|
12 |
4.4K |
2 |
02/06/18 |
02/06/18 |
ASX - By Stock
|
12
|
4.4K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Effective in Preclinical Model of Diabetic Wounds
|
|
imagine
|
12 |
4.4K |
5 |
02/06/18 |
02/06/18 |
ASX - By Stock
|
12
|
4.4K
|
5
|
|
ASX - By Stock
|
CYP |
Effective in Preclinical Model of Diabetic Wounds
|
|
imagine
|
12 |
4.4K |
19 |
02/06/18 |
02/06/18 |
ASX - By Stock
|
12
|
4.4K
|
19
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata's MSCs Effective in Model of Diabetic Wounds
|
|
imagine
|
29 |
9.9K |
3 |
31/05/18 |
31/05/18 |
ASX - By Stock
|
29
|
9.9K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
imagine
|
75 |
48K |
4 |
30/05/18 |
30/05/18 |
ASX - By Stock
|
75
|
48K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Enrolment Completed in Cynata's Phase 1 Clinical Trial
|
|
imagine
|
51 |
17K |
9 |
25/05/18 |
25/05/18 |
ASX - By Stock
|
51
|
17K
|
9
|
|
ASX - By Stock
|
CYP |
Cynata Therapeutics attended
|
|
imagine
|
0 |
329 |
1 |
24/05/18 |
24/05/18 |
ASX - By Stock
|
0
|
329
|
1
|
|
ASX - By Stock
|
CYP |
this report is brought to you by Cynata Therapeutics
|
|
imagine
|
2 |
1.2K |
8 |
08/05/18 |
08/05/18 |
ASX - By Stock
|
2
|
1.2K
|
8
|
|
ASX - By Stock
|
CYP |
Dr. Robert J. Hariri Honored At Unite to Cure
|
|
imagine
|
0 |
448 |
4 |
05/05/18 |
05/05/18 |
ASX - By Stock
|
0
|
448
|
4
|
|
ASX - By Stock
|
CYP |
Reports IMAX (IMAX) and CYNATA THERAPEUTICS LTD
|
|
imagine
|
2 |
1.9K |
0 |
28/04/18 |
28/04/18 |
ASX - By Stock
|
2
|
1.9K
|
0
|
|
ASX - By Stock
|
CYP |
Cynata Therapeutics Limited (CYP) Rise 0.72% on Apr 22
|
|
imagine
|
4 |
1.7K |
5 |
24/04/18 |
24/04/18 |
ASX - By Stock
|
4
|
1.7K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cyanta to Present at ARM Investor Day
|
|
imagine
|
42 |
13K |
1 |
13/04/18 |
13/04/18 |
ASX - By Stock
|
42
|
13K
|
1
|
|
ASX - By Stock
|
CYP |
Novartis just handed out a $8.7 billion endorsement
|
|
imagine
|
0 |
489 |
4 |
10/04/18 |
10/04/18 |
ASX - By Stock
|
0
|
489
|
4
|
|
ASX - By Stock
|
CYP |
Celgene hunts deals to offset loss of Revlimid patent protection
|
|
imagine
|
0 |
461 |
9 |
09/04/18 |
09/04/18 |
ASX - By Stock
|
0
|
461
|
9
|
|
ASX - By Stock
|
CYP |
Why Are There Only 10 Cell and Gene Therapies in Europe?
|
|
imagine
|
0 |
440 |
3 |
05/04/18 |
05/04/18 |
ASX - By Stock
|
0
|
440
|
3
|
|
ASX - By Stock
|
CYP |
Cellectis and Allogene Therapeutics
|
|
imagine
|
0 |
389 |
3 |
05/04/18 |
05/04/18 |
ASX - By Stock
|
0
|
389
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Pfizer in deal with Allogene
|
|
imagine
|
1 |
780 |
1 |
05/04/18 |
05/04/18 |
ASX - By Stock
|
1
|
780
|
1
|
|
ASX - By Stock
|
CYP |
Pfizer in deal with Allogene
|
|
imagine
|
1 |
780 |
2 |
05/04/18 |
05/04/18 |
ASX - By Stock
|
1
|
780
|
2
|
|
ASX - By Stock
|
CYP |
Re:
IPO's and valuations
|
|
imagine
|
246 |
84K |
4 |
04/04/18 |
04/04/18 |
ASX - By Stock
|
246
|
84K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
IPO's and valuations
|
|
imagine
|
246 |
84K |
13 |
03/04/18 |
03/04/18 |
ASX - By Stock
|
246
|
84K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
IPO's and valuations
|
|
imagine
|
246 |
84K |
7 |
03/04/18 |
03/04/18 |
ASX - By Stock
|
246
|
84K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Cynata receives key FDA approval
|
|
imagine
|
9 |
2.9K |
6 |
29/03/18 |
29/03/18 |
ASX - By Stock
|
9
|
2.9K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Cynata receives key FDA approval
|
|
imagine
|
9 |
2.9K |
5 |
29/03/18 |
29/03/18 |
ASX - By Stock
|
9
|
2.9K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Cynata receives key FDA approval
|
|
imagine
|
9 |
2.9K |
11 |
29/03/18 |
29/03/18 |
ASX - By Stock
|
9
|
2.9K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Cynata receives key FDA approval
|
|
imagine
|
9 |
2.9K |
4 |
29/03/18 |
29/03/18 |
ASX - By Stock
|
9
|
2.9K
|
4
|
|
ASX - By Stock
|
CYP |
Cynata receives key FDA approval
|
|
imagine
|
9 |
2.9K |
20 |
29/03/18 |
29/03/18 |
ASX - By Stock
|
9
|
2.9K
|
20
|
|
ASX - By Stock
|
CYP |
Re:
Intellectual Property
|
|
imagine
|
3 |
2.4K |
4 |
23/03/18 |
23/03/18 |
ASX - By Stock
|
3
|
2.4K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Cymerus.... an egos jewel
|
|
imagine
|
41 |
11K |
3 |
21/03/18 |
21/03/18 |
ASX - By Stock
|
41
|
11K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Valuation $3.71 today, increasing to $9 + plus corporate activity
|
|
imagine
|
67 |
27K |
1 |
20/03/18 |
20/03/18 |
ASX - By Stock
|
67
|
27K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
IPO's and valuations
|
|
imagine
|
246 |
84K |
0 |
15/03/18 |
15/03/18 |
ASX - By Stock
|
246
|
84K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
My 10 reasons to BUY at these levels
|
|
imagine
|
22 |
8.4K |
4 |
08/03/18 |
08/03/18 |
ASX - By Stock
|
22
|
8.4K
|
4
|
|